脓毒性休克死亡率作为医院绩效指标的评估
该回顾性队列研究纳入美国急性期医院308家、56,673例入院时脓毒性休克患者,分别用隐式诊断标准(抗生素、培养和升压药收费)或显式ICD-9编码识别病例。采用分层logistic回归计算医院风险标化死亡率和绩效离群值,用Kappa和组内相关系数评估两种定义下医院死亡率排名和离群状态的一致性。结果显示仅19,136例(33.8%)同时满足两种定义,医院风险标化死亡率变异大,两种定义下医院排名中位绝对差37位,离群医院识别一致性中等(kappa 0.44)。作者认为脓毒性休克是重要绩效目标,但死亡率指标对病例定义敏感,目前尚不宜广泛用作医院质量指标。
要点
- 仅19,136/56,673例(33.8%)同时满足ICD-9编码和隐式诊断两种脓毒性休克定义。
- 医院风险标化脓毒性休克死亡率变异大:隐式诊断四分位距25.4-33.5%,ICD-9诊断30.2-38.0%。
- 两种病例定义下医院排名中位绝对差37位(四分位距16-70),组内相关系数0.72(P<0.001)。
- 两种定义识别离群医院的一致性中等:kappa 0.44(95%CI 0.30-0.58)。
- 作者认为脓毒性休克是重要绩效目标,但死亡率指标对病例定义敏感,目前尚不宜广泛用作医院质量指标。
适用人群与场景
- 美国急性期医院入院时脓毒性休克的住院患者,分别由隐式诊断标准(抗生素、培养和升压药收费)或显式ICD-9编码识别。
诊断标准与关键阈值
- 隐式诊断标准:抗生素、培养和升压药收费。
- 显式诊断标准:ICD-9编码。
研究设计与关键结果
- 研究类型:回顾性队列研究;样本量56,673例,来自308家美国急性期医院,均至少满足一种脓毒性休克病例定义。
- 仅19,136例(33.8%)同时满足ICD-9编码和隐式诊断两种脓毒性休克定义。
- 医院风险标化脓毒性休克死亡率变异大:隐式诊断四分位距25.4-33.5%,ICD-9诊断四分位距30.2-38.0%。
- 两种定义下医院排名中位绝对差37位(四分位距16-70),组内相关系数0.72(P<0.001)。
- 两种定义识别离群医院的一致性中等:kappa 0.44(95%CI 0.30-0.58)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为脓毒性休克是重要绩效目标,但死亡率指标对病例定义敏感,目前尚不宜广泛用作医院质量指标。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Sepsis care is becoming a more common target for hospital performance measurement, but few studies have evaluated the acceptability of sepsis or septic shock mortality as a potential performance measure. In the absence of a gold standard to identify septic shock in claims data, we assessed agreement and stability of hospital mortality performance under different case definitions.
DESIGN: Retrospective cohort study.
SETTING: U.S. acute care hospitals.
PATIENTS: Hospitalized with septic shock at admission, identified by either implicit diagnosis criteria (charges for antibiotics, cultures, and vasopressors) or by explicit International Classification of Diseases, 9th revision, codes.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We used hierarchical logistic regression models to determine hospital risk-standardized mortality rates and hospital performance outliers. We assessed agreement in hospital mortality rankings when septic shock cases were identified by either explicit International Classification of Diseases, 9th revision, codes or implicit diagnosis criteria. Kappa statistics and intraclass correlation coefficients were used to assess agreement in hospital risk-standardized mortality and hospital outlier status, respectively. Fifty-six thousand six-hundred seventy-three patients in 308 hospitals fulfilled at least one case definition for septic shock, whereas 19,136 (33.8%) met both the explicit International Classification of Diseases, 9th revision, and implicit septic shock definition. Hospitals varied widely in risk-standardized septic shock mortality (interquartile range of implicit diagnosis mortality: 25.4-33.5%; International Classification of Diseases, 9th revision, diagnosis: 30.2-38.0%). The median absolute difference in hospital ranking between septic shock cohorts defined by International Classification of Diseases, 9th revision, versus implicit criteria was 37 places (interquartile range, 16-70), with an intraclass correlation coefficient of 0.72, p value of less than 0.001; agreement between case definitions for identification of outlier hospitals was moderate (kappa, 0.44 [95% CI, 0.30-0.58]).
CONCLUSIONS: Risk-standardized septic shock mortality rates varied considerably between hospitals, suggesting that septic shock is an important performance target. However, efforts to profile hospital performance were sensitive to septic shock case definitions, suggesting that septic shock mortality is not currently ready for widespread use as a hospital quality measure.
参考来源
- Walkey AJ, Shieh MS, Liu VX, et al. Mortality Measures to Profile Hospital Performance for Patients With Septic Shock. Crit Care Med. 2018. PMID: 29727371. doi:10.1097/CCM.0000000000003184
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。